saxenda glp 1 agonist Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://cdn.sanity.io/images/0vv8moc6/drugtopics/95e97d281e5924cde2da30014f9dab359d32abfa-7200x3600.jpg)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://static.wixstatic.com/media/966baf_10d0068dbc5d4509afc0140d70a22a29~mv2.jpg/v1/fill/w_960,h_540,al_c,q_85,enc_avif,quality_auto/966baf_10d0068dbc5d4509afc0140d70a22a29~mv2.jpg)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://www.americanmedspa.org/wp-content/uploads/2026/03/semaglutide-hero.jpg)
















/product/89/3115914/1.jpg?1207)







